跳至主要内容
临床试验/CTRI/2017/08/009579
CTRI/2017/08/009579招募中2 期

A prospective study to evaluate the safety and efficacy of Carica papaya leaf extract (Oral Caripill) in the treatment of severe thrombocytopenia (s30,000/µl) in dengue - AIMSCARI

Micro Labs Limited0 个研究点目标入组 84 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
招募中
入组人数
84

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1.Provide signed and dated informed consent form
  • 2.Willing to comply with all study procedures and be available for the duration of the study
  • 3.Male or female, aged greater than or equal to 18 yrs of age. Clinically diagnosed of dengue and a peripheral platelet count of less than or equal to 30,000/µL.
  • 4.A laboratory positive diagnosis of dengue confirmed by a positive NS1 ELISA test and/or detection of viral RNA by real time PCR assay.

排除标准

  • 1.Pregnancy and lactation.
  • 2.Patients who has been given steroids for thrombocytopenia and also those who have been transfused platelets before starting the drug
  • 3.Taking indigenous medicines.
  • 4.Creatine kinase (CK) >1000 U/L

研究者

相似试验

A clinical trial to study the effects of Caripill... | 临床试验